John Tynan, VG Life Sciences Inc.'s President, CEO and director, shall be resigning effective April 1, 2016. David Odell, the Company's CFO and director, shall be resigning effective April 1, 2016. Effective as of April 1, 2016, the Company's Chief Operating Officer, Jill Deering, shall be resigning.

Effective as of April 1, 2016, the Company's Controller, Mr. Caleb Rhoads, shall be resigning. As of April 1, 2016, the Company's new CEO and CFO shall be Haig Keledjian, who was previously serving as Vice President of Research and Development and Secretary for the Company. Mr. Keledjian shall continue to serve as Vice President of Research and Development and Secretary, in addition to serving as CEO and CFO, for the Company.

Mr. Keledjian shall also serve as director for the Company.